-+ 0.00%
-+ 0.00%
-+ 0.00%

Cabaletta Bio prices 51,725,000-share offering at $2.9, raises $150 million

PUBT·05/04/2026 10:36:12
Listen to the news
Cabaletta Bio prices 51,725,000-share offering at $2.9, raises $150 million
  • Cabaletta Bio priced an underwritten follow-on offering of 51,725,000 common shares, targeting gross proceeds of about USD 150 million.
  • Offering priced at USD 2.9 per share, described as at-the-market under Nasdaq rules.
  • Closing expected on or about May 5, 2026, subject to customary conditions.
  • Bain Capital Life Sciences, Adage Capital Management, Cormorant Asset Management, other existing investors, new mutual and sovereign wealth funds, Eli Lilly participated.
  • TD Cowen, Guggenheim Securities, Cantor serving as joint bookrunners; H.C. Wainwright acting as lead manager.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cabaletta Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040635PRIMZONEFULLFEED9712227) on May 04, 2026, and is solely responsible for the information contained therein.